News
News releases on January 8, 2023
Every news release public companies put out on January 8, 2023 (UTC): 16 news releases, newest first. Open any release to read it.
Línea Directa Aseguradora S A: Línea Directa launches the first joint car and home insurance offer in Spain with a guaranteed saving
Linea Directa Aseguradora SA · Jan 8, 2023
Farmacosmo S p A: Enters The World Of Pet Care And Launches The Marketing Strategy Of Own-Brand Products In The Sector
Farmacosmo S.P.A. · Jan 8, 2023
Press Release Jan 08 2023
One 97 Communications Ltd. · Jan 8, 2023
Press Release Jan 08 2023
Infosys Limited · Jan 8, 2023
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating Low Dose VRDN-001 in Patients with Thyroid Eye Disease (TED)
Viridian Therapeutics, Inc. · Jan 8, 2023
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results
RxSight, Inc. · Jan 8, 2023
Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for ...
Phathom Pharmaceuticals, Inc. · Jan 8, 2023
Exelixis Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results, Provides 2023 Financial Guidance, and Outlines Key Pr...
Exelixis, Inc. · Jan 8, 2023
Esperion Outlines Upcoming Milestones and Announces Preliminary Fourth Quarter 2022 Financial Results
Esperion Therapeutics, Inc. · Jan 8, 2023
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2022 Results
Castle Biosciences, Inc. · Jan 8, 2023
BioMarin Announces Stable and Durable Annualized Bleed Control for ROCTAVIAN™ in Largest Phase 3 Gene Therapy Study in Adults with Severe...
BioMarin Pharmaceutical Inc. · Jan 8, 2023
Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three ...
Annexon, Inc. · Jan 8, 2023
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2022 Global Net Product Revenues and Provides Additional Updates
Alnylam Pharmaceuticals, Inc. · Jan 8, 2023
Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company’s Vision to Transform Patient Outcomes in Rare Diseases
Agios Pharmaceuticals, Inc. · Jan 8, 2023
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Absci Corporation · Jan 8, 2023
Press Release Jan 07 2023
Hi-Tech Pipes Ltd. · Jan 8, 2023